tirzepatide in vienna 📢 Speaker Highlight! Join Prof. David A. D'Alessio at #EASD2025 in Vienna Obesity drug seen as effective

Research shows that people living with chronic pain conditions often struggle with weight management, partly due to reduced mobility and medication side effects

Research examples presented in Table 4 show that an additional survey should be conducted in order to confirm this theory

B.DaveA.RomanoA.ForresterS.de FariaP

Most clinics dont refuse IVF simply because someone is using a GLP-1 medication

When using the available research as a reference, the recommended starting dose of tirzepatide is 2.5mg/weekly, and it can be increased every four weeks up to a maximum of 15mg/weekly [24]

Common side effects include nausea, vomiting, and constipation, particularly when first starting the medication